Related Experiment Video
Updated: Oct 18, 2025

A Two-Step Method for Percutaneous Transhepatic Choledochoscopic Lithotomy
Published on: September 13, 2022
Correlates of gallbladder stones among patients with sickle cell disease: A meta-analysis
Sagad O O Mohamed1, Omer A O Ibrahim2, Dahlia A A Mohammad3
1Department of Paediatrics and Child Health, Faculty of Medicine University of Khartoum Khartoum Sudan.
Insights
Gallstones (cholelithiasis) affect about 25% of sickle cell disease (SCD) patients. Lower hemoglobin and higher bilirubin levels are linked to increased gallstone risk in SCD.
Area of Science:
- Hematology
- Genetics
- Gastroenterology
Background:
- Sickle cell disorders are prevalent global hemoglobinopathies.
- Sickle cell disease (SCD) exhibits significant clinical variability and complication susceptibility.
- Cholelithiasis is a common complication in SCD patients.
Purpose of the Study:
- To summarize and analyze the prevalence of cholelithiasis in SCD patients.
- To identify factors associated with cholelithiasis development in SCD.
Main Methods:
- Systematic database search across multiple scientific literature repositories.
- Meta-analysis of 34 eligible studies using Comprehensive Meta-Analysis Software.
- Calculation of pooled prevalence, odds ratio (OR), and standardized mean difference (SMD) with 95% confidence intervals (CI).
Main Results:
- Overall prevalence of cholelithiasis in SCD patients was 25.3% (95% CI 19.4-32.3%).
- Significant associations found between cholelithiasis and lower total hemoglobin (SMD = -0.45, P = 0.002) and hemoglobin F (HbF) levels (SMD = -0.85, P = 0.003).
- Higher total serum bilirubin (SMD = 1.15, P < 0.001), higher reticulocyte count (SMD = 0.44, P = 0.007), and UGT1A1 promoter polymorphism were also significantly associated with increased risk.
Conclusions:
- SCD patients experience a high rate of cholelithiasis.
- Hematologic parameters like hemoglobin levels and bilirubin are key factors influencing cholelithiasis risk.
- Genetic factors, specifically UGT1A1 polymorphism, play a role in SCD-related cholelithiasis.
Abstract:
Sickle cell disorders are the most common hemoglobinopathies worldwide. Clinical variability of sickle cell disease (SCD) and susceptibility to its complications have been attributed to hematologic, genetic, and other influencing factors. This review aimed to provide further summary and analyses of the prevalence and factors associated with cholelithiasis among patients with SCD. A systematic database search was conducted in MEDLINE (PubMed), ScienceDirect, Google Scholar, World Health Organization Virtual Health Library, Cochrane Library databases, and System for Information on Gray Literature in Europe (SIGLE). Pooled prevalence, odds ratio (OR), and standardized mean difference (SMD) with the corresponding 95% confidence interval (CI) were calculated using Comprehensive Meta-Analysis Software version 3.3. A total of 34 studies that fulfilled the eligibility criteria were included in the analyses. The overall prevalence of cholelithiasis among SCD patients was 25.3% (95% CI 19.4-32.3%). The risk of developing cholelithiasis was significantly associated with lower total hemoglobin level (SMD = -0.45; P = 0.002), lower hemoglobin F (HbF) level (SMD = -0.85; P = 0.003), higher total serum bilirubin level (SMD = 1.15; P < 0.001), higher reticulocytes count (SMD = 0.44; P = 0.007), and UDP-glucuronosyltransferase-1A1 enzyme (UGT1A1) promoter polymorphism. This review provides a comprehensive view of the high rate of cholelithiasis and its associated factors in SCD patients.
Related Concept Videos
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Gallbladder
The gallbladder's anatomy consists of three regions: the fundus, body, and neck. Extending from the neck, the cystic duct joins...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Urinary Tract Calculi III: Medical Management
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

